14549-67-8

Basic information

• Product Name: 1-(3-Amino-4-pyridyl)-4-(2,4-dimethoxyphenyl)piperazine
• Synonyms: 1-(3-Amino-4-pyridyl)-4-(2,4-dimethoxyphenyl)piperazine;4-[4-(2,4-Dimethoxyphenyl)-1-piperazinyl]-3-pyridinamine
• CAS NO: 14549-67-8
• Molecular Formula: C17H22 N4 O2
• Molecular Weight: 314.38
• Mol File: 14549-67-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 558.1°C at 760 mmHg
• Flash Point: 291.3°C
• Appearance: /
• Density: 1.207g/cm³
• Vapor Pressure: 1.72E-12mmHg at 25°C
• Refractive Index: 1.608
• CAS DataBase Reference: 1-(3-Amino-4-pyridyl)-4-(2,4-dimethoxyphenyl)piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-Amino-4-pyridyl)-4-(2,4-dimethoxyphenyl)piperazine(14549-67-8)
• EPA Substance Registry System: 1-(3-Amino-4-pyridyl)-4-(2,4-dimethoxyphenyl)piperazine(14549-67-8)

Safety Data

• Hazardous Substances Data: 14549-67-8(Hazardous Substances Data)

Usage

Chemical structure

The compound consists of a piperazine ring with a pyridine group and a 2,4-dimethoxyphenyl group attached.

Pharmaceutical research

It is commonly used in pharmaceutical research as a potential therapeutic agent for various conditions.

Psychiatric disorders

The compound has been studied for its potential use in treating psychiatric disorders due to its ability to interact with neurotransmitter receptors.

Cancer treatment

It has been investigated as a potential antitumor agent, making it a candidate for further research in cancer treatment.

Interaction with neurotransmitter receptors

The compound's ability to interact with neurotransmitter receptors is a key factor in its potential therapeutic applications.

Drug candidate

Its chemical structure and properties make it a promising candidate for further investigation and development as a drug.

Dimethoxyphenyl group

The presence of the 2,4-dimethoxyphenyl group in the compound contributes to its unique properties and potential therapeutic applications.

Amino and pyridyl groups

The 3-amino-4-pyridyl group attached to the piperazine ring is responsible for the compound's interaction with neurotransmitter receptors and its potential therapeutic effects.

Molecular weight

The molecular weight of the compound is an important factor in determining its pharmacokinetics and pharmacodynamics.

Solubility

The solubility of the compound in various solvents can impact its formulation and administration in potential therapeutic applications.

Stability

The stability of the compound under different conditions (e.g., temperature, pH) is crucial for its development as a drug candidate.

Toxicity

The compound's toxicity profile is an essential aspect to consider during the drug development process, as it can impact its safety and efficacy.

Synergistic effects

The compound may have synergistic effects when combined with other therapeutic agents, which could enhance its potential therapeutic applications.

Structure-activity relationship

Understanding the relationship between the compound's structure and its biological activity can help guide the design of more potent and selective drug candidates.

Patentability

The compound's unique structure and potential therapeutic applications may make it eligible for patent protection, which could encourage further research and development.

InChI:InChI=1/C17H22N4O2/c1-22-13-3-4-16(17(11-13)23-2)21-9-7-20(8-10-21)15-5-6-19-12-14(15)18/h3-6,11-12H,7-10,18H2,1-2H3